|
LOC401397 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.59989999998422E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.6554000000022E-05 |
| Normal-vs-Stage2 |
8.744200E-02 |
| Normal-vs-Stage3 |
2.263600E-01 |
| Normal-vs-Stage4 |
4.235100E-03 |
| Stage1-vs-Stage2 |
9.657200E-01 |
| Stage1-vs-Stage3 |
1.156570E-01 |
| Stage1-vs-Stage4 |
8.694000E-01 |
| Stage2-vs-Stage3 |
3.090800E-01 |
| Stage2-vs-Stage4 |
9.234200E-01 |
| Stage3-vs-Stage4 |
1.709030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.37970000005472E-06 |
| Normal-vs-AfricanAmerican |
1.283500E-02 |
| Normal-vs-Asian |
3.359600E-01 |
| Caucasian-vs-AfricanAmerican |
4.790800E-01 |
| Caucasian-vs-Asian |
9.493400E-01 |
| AfricanAmerican-vs-Asian |
7.897400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.13830000039827E-07 |
| Normal-vs-Female |
1.114580E-01 |
| Male-vs-Female |
7.057700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.058400E-01 |
| Normal-vs-Extreme_Weight |
4.70239999994515E-06 |
| Normal-vs-Obese |
1.279840E-02 |
| Normal-vs-Extreme_Obese |
3.347700E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.535700E-02 |
| Normal_Weight-vs-Obese |
5.815200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.449000E-01 |
| Extreme_Weight-vs-Obese |
1.087350E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.389400E-01 |
| Obese-vs-Extreme_Obese |
2.435600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.709210E-01 |
| Normal-vs-Age(41-60Yrs) |
2.11319999999793E-05 |
| Normal-vs-Age(61-80Yrs) |
1.573790E-04 |
| Normal-vs-Age(81-100Yrs) |
1.051550E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.719000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.766800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.013200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.944000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.462600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.678800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.74950087539605E-11 |
| Normal-VS-Type2 PRCC |
4.640400E-01 |
| Normal-VS-KIRP CIMP |
3.428600E-01 |
| Normal-VS-Unclassified PRCC |
4.701600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.56279999999443E-07 |
| Type1 PRCC-VS-KIRP CIMP |
1.84889000000021E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
4.944200E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.561360E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.549200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.962100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.765800E-02 |
| Normal-vs-N1 |
2.248800E-01 |
| Normal-vs-N2 |
8.151800E-01 |
| N0-vs-N1 |
3.411800E-01 |
| N0-vs-N2 |
5.500200E-01 |
| N1-vs-N2 |
7.379600E-01 |
|
|
